Glutathione and kidney disease: a proposed research direction

Why this matters

Explore why glutathione is studied in kidney disease without assuming a product improves kidney function.

How the pieces connect

Oxidative stress and inflammation are studied in kidney disease. A reason to study glutathione is different from proof that a product improves kidney outcomes.

Keep kidney outcomes separate from antioxidant markers

Dr. Purser’s hypothesis moves from redox biology to a proposed clinical benefit. Those steps need different evidence. A change in an antioxidant or cytokine measurement is not, by itself, proof of preserved kidney function. The important clinical questions concern kidney-function trends, urine findings, symptoms and outcomes over time. Chronic kidney disease also has established contributors, including diabetes and high blood pressure, which must not disappear from the discussion when a new biochemical model is introduced.

A question for your next conversation

What direct evidence shows a kidney benefit from this exact intervention?

LET YOUR CURIOSITY LEAD

One idea opens another.

Choose a subject to find the related teaching across videos, articles, courses and references.